November 21, 2026 | 11:00

MSD & VNVC take important step toward technology transfer, manufacturing, and localization of strategic vaccine technology products

Announcement of planned collaboration a key milestone during visit by MSD’s senior leadership team to Vietnam.

In the presence of Minister of Health Dao Hong Lan, Deputy Minister of Science and Technology Le Xuan Dinh, Deputy Minister of Foreign Affairs Dang Hoang Giang, and representatives of relevant government agencies, MSD and the Vietnam Vaccine Joint Stock Company (VNVC) announced a plan to collaborate on the technology transfer, manufacturing, and localization of strategic vaccine technology products.

VNVC and MSD leaders meet with Deputy Prime Minister Pham Thi Thanh Tra to discuss Vietnam’s healthcare priorities, the role of science, technology, and innovation in advancing healthcare, and opportunities to strengthen collaboration between the government and the private sector. (Photo: VGP)
VNVC and MSD leaders meet with Deputy Prime Minister Pham Thi Thanh Tra to discuss Vietnam’s healthcare priorities, the role of science, technology, and innovation in advancing healthcare, and opportunities to strengthen collaboration between the government and the private sector. (Photo: VGP)

The announcement marks a key milestone during the visit of MSD’s senior leadership team to Vietnam, laying the groundwork for further steps toward the long-term transfer of scientific knowledge, technical expertise, quality processes, and manufacturing capabilities to VNVC. The ceremony brought together Dr. Marc Gailhardou, President of MSD’s Intercontinental Region; Dr. Andrew Otoo, President of MSD in Asia Pacific, Mr. Ngo Chi Dung, VNVC’s Chairman and CEO, and other key stakeholders.

In the presence of leaders from the Ministry of Health, the Ministry of Science and Technology, and the Ministry of Foreign Affairs, MSD and VNVC announced a plan to collaborate on the technology transfer, manufacturing, and localization of strategic vaccine technology products. (Photo: Phan Tuan)
In the presence of leaders from the Ministry of Health, the Ministry of Science and Technology, and the Ministry of Foreign Affairs, MSD and VNVC announced a plan to collaborate on the technology transfer, manufacturing, and localization of strategic vaccine technology products. (Photo: Phan Tuan)

“MSD looks forward to bringing more than 130 years of global expertise to this planned partnership,” said Dr. Gailhardou. “We are equally encouraged by VNVC’s local leadership, investment, and long-term vision. By combining our respective strengths, we hope to support stronger disease prevention efforts and deliver lasting benefits for the health of the Vietnamese people.”

Dr. Marc Gailhardou, President of MSD’s Intercontinental Region, shares MSD’s vision for its planned collaboration with VNVC to advance disease prevention and make a lasting contribution to the health of people in Vietnam.
Dr. Marc Gailhardou, President of MSD’s Intercontinental Region, shares MSD’s vision for its planned collaboration with VNVC to advance disease prevention and make a lasting contribution to the health of people in Vietnam.

Mr. Dung said VNVC has worked closely with MSD for many years to bring millions of vaccine doses to people in Vietnam each year. Building on this successful collaboration, the two parties are working toward a strategic cooperation plan covering technology transfer, manufacturing, and localization of strategic vaccine technology product, contributing to Vietnam’s vision of advancing science and technology and strengthening healthcare self-reliance.

“VNVC views high-tech vaccine manufacturing a long-term strategy that requires significant investment in technology, human resources, and quality management,” he continued. “We have invested in the development of a modern manufacturing facility and are building the foundation to receive and progressively master advanced technologies. Our plan to collaborate with MSD marks an important step forward, opening opportunities to access world-leading vaccine manufacturing technologies, strengthen domestic supply capabilities, expand access to vaccines, and enhance Vietnam’s position in the global vaccine industry.”

Later that day, MSD leaders met with Deputy Prime Minister Pham Thi Thanh Tra, where discussions focused on Vietnam’s healthcare priorities, the role of science, technology, and innovation in advancing healthcare, and opportunities to strengthen collaboration between the government and the private sector. During the meeting, MSD shared details of its plan to collaborate with VNVC on the technology transfer, manufacturing, and localization of strategic vaccine technology products, reflecting its long-term commitment to Vietnam. The parties also explored ways to expand access to innovative medicines and high-quality vaccines while contributing to a more sustainable healthcare system.

MSD’s planned partnership with VNVC, together with its high-level engagements during the visit, reinforces the role of partnership, science, and innovation in supporting the sustainable development of Vietnam’s healthcare system.

Attention
The original article is written and published on VnEconomy in Vietnamese, then translated into English by Askonomy – an AI platform developed by Vietnam Economic Times/VnEconomy – and published on En-VnEconomy. To read the full article, please use the Google Translate tool below to translate the content into your preferred language.
However, VnEconomy is not responsible for any translation by the Google Translate.

Google translateGoogle translate